Abstract:Background: Resveratrol have been known to possess many pharmacological properties including antioxidant, cardioprotective and anticancer effects. Although current studies indicate that resveratrol produces neuroprotection against neurological disorders, the precise mechanisms for its beneficial effects are still not fully understood. We investigate the effect of anti-inflammatory and mechamisms of resveratrol by using lipopolysaccharide (LPS)-stimulated murine microglial BV-2 cells.Methodology/Principal Findings: BV-2 cells were treated with resveratrol (25, 50, and 100 mu M) and/or LPS (1 mu g/ml). Nitric oxide (NO) and prostaglandin E2 (PGE2) were measured by Griess reagent and ELISA. The mRNA and protein levels of proinflammatory proteins and cytokines were analysed by RT-PCR and double immunofluorescence labeling, respectively. Phosphorylation levels of PTEN (phosphatase and tensin homolog deleted on chromosome 10), Akt, mammalian target of rapamycin (mTOR), mitogen-activated protein kinases (MAPKs) cascades, inhibitor kappa B-alpha (I kappa B-alpha) and cyclic AMP-responsive element-binding protein (CREB) were measured by western blot. Resveratrol significantly attenuated the LPS-induced expression of NO, PGE2, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and nuclear factor-kappa B (NF-kappa B) in BV-2 cells. Resveratrol increased PTEN, Akt and mTOR phosphorylation in a dose-dependent manner or a time-dependent manner. Rapamycin (10 nM), a specific mTOR inhibitor, blocked the effects of resveratrol on LPS-induced microglial activation. In addition, mTOR inhibition partially abolished the inhibitory effect of resveratrol on the phosphorylation of I kappa B-alpha, CREB, extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK).Conclusion and Implications: This study indicates that resveratrol inhibited LPS-induced proinflammatory enzymes and proinflammatory cytokines via down-regulation phosphorylation of NF-kappa B, CREB and MAPKs family in a mTOR-dependent manner. These findings reveal, in part, the molecular basis underlying the anti-inflammatory properties of resveratrol.

Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells.

Resveratrol Inhibits Macrophage Expression of EMMPRIN by Activating PPARγ

Resveratrol Inhibits Expression of EMMPRIN from Macrophages

Resveratrol Attenuates Thromboxane A2 Receptor Agonist-Induced Platelet Activation by Reducing Phospholipase C Activity.

Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in Arat Model.

Resveratrol Downregulates Acute Pulmonary Thromboembolism-Induced Pulmonary Artery Hypertension Via P38 Mitogen-Activated Protein Kinase and Monocyte Chemoattractant Protein-1 Signaling in Rats.

Inhibitory Effect of Ppar on the Expression of Emmprin in Macrophages and Foam Cells

Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages

Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF-κB/STAT3 Activation in Ox-LDL-Treated HUVECs

Inhibition of Emmprin and Mmp-9 Expression by Epigallocatechin-3-Gallate Through 67-Kda Laminin Receptor in Pma-Induced Macrophages

Artemisinin Inhibits Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and Matrix Metalloproteinase‐9 Expression Via a Protein Kinase Cδ/p38/extracellular Signal‐regulated Kinase Pathway in Phorbol Myristate Acetate‐induced THP‐1 Macrophages

EMMPRIN mediates matrix metalloproteinase 9 expression and monocyte migration: evidence from EMMPRIN knockdown by RNA interference

Resveratrol inhibits matrix metalloproteinase-1 and -3 expression by suppressing of p300/NFκB acetylation in TNF-α-treated human dermal fibroblasts

Berberine Reduces Both MMP-9 and EMMPRIN Expression Through Prevention of P38 Pathway Activation in PMA-induced Macrophages

Resveratrol Inhibits MMP-9 Expression by Up-Regulating PPAR Α Expression in an Oxygen Glucose Deprivation-Exposed Neuron Model

Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.

Resveratrol Inhibits Inflammatory Responses Via The Mammalian Target Of Rapamycin Signaling Pathway In Cultured Lps-Stimulated Microglial Cells

Resveratrol Suppresses Lipoprotein-Associated Phospholipase A2 Expression by Reducing Oxidative Stress in Macrophages and Animal Models.

Genome-Wide Transcriptional Profiling Reveals PHACTR1 As a Novel Molecular Target of Resveratrol in Endothelial Homeostasis.

Effect of PPAR Ligands on Extracellular Matrix Metalloproteinase Inducer Expression in Macrophages and Foam Cells

Resveratrol Down-Regulates Endothelin Type B Receptors in Vascular Smooth Muscle Cells Via Sirt1/ERK1/2/NF-кB Signaling Pathways